Welcome to LookChem.com Sign In|Join Free

CAS

  • or
(3R,4S,5R)-3,4-dihydroxy-5-(trityloxymethyl)-dihydrofuran-2(3H)-one is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

84911-43-3

Post Buying Request

84911-43-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

84911-43-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 84911-43-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,4,9,1 and 1 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 84911-43:
(7*8)+(6*4)+(5*9)+(4*1)+(3*1)+(2*4)+(1*3)=143
143 % 10 = 3
So 84911-43-3 is a valid CAS Registry Number.

84911-43-3Relevant articles and documents

FLUORESCENT SUBSTRATES FOR POLY(ADP-RIBOSYL) HYDROLASES

-

Page/Page column 35; 37, (2020/05/06)

The post-translational modification (PTM) and signaling molecule poly(ADP-ribose) (PAR) has an impact on diverse biological processes. PTM is regulated by a series of ADP-ribosyl glycohydrolases (PARG enzymes) that cleave polymers and/or liberate monomers from their protein targets. Disclosed herein is a substrate for monitoring PARG activity, TFMU-ADPr, which directly reports on total PAR hydrolase activity via release of a fluorophore; this substrate has excellent reactivity, generality, stability, and usability. A second substrate, TFMU-IDPr, selectively reports on PARG activity only from the enzyme ARH3. Use of these probes in whole-cell lysate experiments has revealed a mechanism by which ARH3 is inhibited by cholera toxin. TFMU-ADPr and TFMU-IDPr are versatile tools for assessing small-molecule inhibitors in vitro and probing the regulation of ADP-ribosyl catabolic enzymes.

Synthesis of Dimeric ADP-Ribose and Its Structure with Human Poly(ADP-ribose) Glycohydrolase

Lambrecht, Michael J.,Brichacek, Matthew,Barkauskaite, Eva,Ariza, Antonio,Ahel, Ivan,Hergenrother, Paul J.

supporting information, p. 3558 - 3564 (2015/03/30)

Poly(ADP-ribosyl)ation is a common post-translational modification that mediates a wide variety of cellular processes including DNA damage repair, chromatin regulation, transcription, and apoptosis. The difficulty associated with accessing poly(ADP-ribose) (PAR) in a homogeneous form has been an impediment to understanding the interactions of PAR with poly(ADP-ribose) glycohydrolase (PARG) and other binding proteins. Here we describe the chemical synthesis of the ADP-ribose dimer, and we use this compound to obtain the first human PARG substrate-enzyme cocrystal structure. Chemical synthesis of PAR is an attractive alternative to traditional enzymatic synthesis and fractionation, allowing access to products such as dimeric ADP-ribose, which has been detected but never isolated from natural sources. Additionally, we describe the synthesis of an alkynylated dimer and demonstrate that this compound can be used to synthesize PAR probes including biotin and fluorophore-labeled compounds. The fluorescently labeled ADP-ribose dimer was then utilized in a general fluorescence polarization-based PAR-protein binding assay. Finally, we use intermediates of our synthesis to access various PAR fragments, and evaluation of these compounds as substrates for PARG reveals the minimal features for substrate recognition and enzymatic cleavage. Homogeneous PAR oligomers and unnatural variants produced from chemical synthesis will allow for further detailed structural and biochemical studies on the interaction of PAR with its many protein binding partners. (Chemical Equation Presented).

Yarrowia lipolytica dehydrogenase/reductase: An enzyme tolerant for lipophilic compounds and carbohydrate substrates

Napora, Kamila,Wrodnigg, Tanja M.,Kosmus, Patrick,Thonhofer, Martin,Robins, Karen,Winkler, Margit

, p. 3393 - 3395 (2013/06/27)

Yarrowia lipolytica short chain dehydrogenase/reductase (YlSDR) was expressed in Escherichia coli, purified and characterized in vitro. The substrate scope for YlSDR mediated oxidation was investigated with alcohols and unprotected carbohydrates spectrophotometrically, revealing a preference for secondary compared to primary alcohols. In reduction direction, YlSDR was highly active on ribulose and fructose, suggesting that the enzyme is a mannitol-2-dehydrogenase. In order to explore substrate tolerance especially for space-demanding, lipophilic protecting groups, 5-O-trityl-d-ribitol and 5-O-trityl-α,β-d-ribose were investigated as substrates: YlSDR oxidized 5-O-trityl-d-ribitol and 5-O-trityl-α,β-d-ribose and reduced the latter at the expense of NADP(H).

Regioselective electrophilic substitution of 2,3-aziridino-γ-lactones: preliminary studies aimed at the synthesis of α,α-disubstituted α- or β-amino acids

Valle, Marcelo Siqueira,Tarrade-Matha, Aurélie,Dauban, Philippe,Dodd, Robert H.

, p. 419 - 432 (2008/04/01)

2,3-Aziridino-γ-lactones are versatile synthons for the preparation of polysubstituted α- or β-amino acids. With the intention of preparing α,α-disubstituted α- or β-amino acids, regioselective electrophilic substitution of aziridino-γ-lactones at C2 was

Synthesis of 5-deoxy-5-phospho-D-ribonohydroxamic acid: A new competitive and selective inhibitor of type B ribose-5-phosphate isomerase from Mycobacterium tuberculosis

Burgos, Emmanuel,Roos, Annette K.,Mowbray, Sherry L.,Salmon, Laurent

, p. 3691 - 3694 (2007/10/03)

5-Deoxy-5-phospho-d-ribonohydroxamic acid, a mimic of the 1,2-cis-enediolate high-energy intermediate species of the allose-6-phosphate isomerase reaction, was obtained by a six-step synthesis from d-erythronolactone. In contrast to the known competitive

Iron-containing nucleoside analogues with pronounced apoptosis-inducing activity

Schlawe, Daniel,Majdalani, Andre,Velcicky, Juraj,Hessler, Erik,Wieder, Thomas,Prokop, Aram,Schmalz, Hans-Guenther

, p. 1731 - 1734 (2007/10/03)

Bioactive organometallic compounds: Iron-containing nucleoside analogues, which can be stereoselectively synthesized in a few steps starting from simple carbohydrates, cause tumor cells to undergo apoptosis (programmed cell death; see picture for the typi

Toward a general strategy for the synthesis of 3,4-dihydroxyprolines from pentose sugars

Taylor, Carol M.,Taylor, Carol M.,Barker, William D.,Weir, Claudette A.,Park, Jae H.

, p. 4466 - 4474 (2007/10/03)

A general strategy is proposed, wherein a pentose sugar γ-lactone can be converted, via a series of nine reactions, to a 3,4-dihydroxyproline, suitably protected for use in peptide synthesis. Thus, D-ribonolactone (6) has been converted to N-fluorenylmethoxycarbonyl-3,4-di-O-tert-butyldimethylsilyloxy-D-2,3-cis-3, 4-cis-proline (7) in 18.9% overall yield. Likewise, L-arabinonolactone (11) has been converted to N-fluorenylmethoxycarbonyl-3,4-di-O-tert-butyldimethylsilyloxy-L-2,3-cis-3, 4-trans-proline (36) in 13.7% overall yield and L-lyxonolactone (12) to N-fluorenylmethoxycarbonyl- 3,4-di-O-tert-butyldimethylsilyloxy-L-2,3-trans-3,4-cis-proline (37) in 11.2% overall yield. These building blocks have also been fully deprotected to give the free amino acids. We believe that this series of reactions ought to be applicable to the synthesis of any of the eight stereoisomers of 3,4-dihydroxyproline, by judicious selection of the pentose starting material.

A new straightforward synthesis of 2,3-aziridino-γ-lactones

De Saint-Fuscien,Tarrade,Dauban,Dodd

, p. 6393 - 6397 (2007/10/03)

A concise synthesis of 2,3-aziridino-γ-lactones starting from commercially available α,β-dihydroxy-γ-lactones is described. The strategy involves a Michael-type addition of benzylamine onto a key 2-(5H)-furanon-3-yl trifluoromethanesulfonate, followed by in situ cyclization to the aziridine without lactone-ring-opening. (C) 2000 Elsevier Science Ltd.

Synthesis of a protected 3,4-dihydroxyproline from a pentose sugar

Weir, Claudette A.,Taylor, Carol M.

, p. 787 - 789 (2008/02/11)

Formula presented D-Ribonolactone (6) was transformed into N-((fluorenylmethoxy)carbonyl)-3,4.bis.O-(tert-butyldimethylsilyl)-D-2,3-cis-3, 4-cis-3,4-dihydroxyproline (13) in nine chemical steps. This represents a potentially general strategy for the synth

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 84911-43-3